Browse by Academic Unit (A-Z)
![[up]](/style/images/multi_up.png)
Up a level- White Rose Consortium (142016)
- The University of Leeds (61216)
- Faculty of Medicine and Health (Leeds) (13772)
- Institute of Molecular Medicine (LIMM) (Leeds) (1213)
- Section of Oncology and Clinical Research (Leeds) (75)
- National Institute for Health Research (Leeds) (4)
- NCRN (NIHR Cancer Research Network) (Leeds) (3)
- National Institute for Health Research (Leeds) (4)
- Section of Oncology and Clinical Research (Leeds) (75)
- Medicine & Health Faculty Office (Leeds) (97)
- National Institute for Health Research (Leeds) (4)
- NCRN (NIHR Cancer Research Network) (Leeds) (3)
- National Institute for Health Research (Leeds) (4)
- Institute of Molecular Medicine (LIMM) (Leeds) (1213)
- Faculty of Medicine and Health (Leeds) (13772)
- The University of Leeds (61216)
C
Cameron, DA, Anderson, A, Toy, E et al. (9 more authors) (2002) Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer? British Journal of Cancer, 87 (12). pp. 1365-1369. ISSN 0007-0920
Coleman, RE, Winter, MC, Cameron, D et al. (11 more authors) (2010) The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer, 102 (7). 1099 - 1105. ISSN 0007-0920
M
Morris, E, Haward, RA, Gilthorpe, MS et al. (2 more authors) (2006) The impact of the Calman–Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients. British Journal of Cancer, 95 (8). pp. 979-985. ISSN 0007-0920